Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy

被引:2
作者
Butz, T. [1 ,2 ]
Horstkotte, D. [2 ]
Koerfer, J. [3 ]
Langer, C. [2 ]
Seggewiss, H. [4 ]
Faber, L. [2 ]
机构
[1] Ruhr Univ Bochum, Dept Cardiol & Angiol, Marienhosp, D-44627 Herne, Germany
[2] Ruhr Univ Bochum, Dept Cardiol, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[3] Ruhr Univ Bochum, Inst Radiol Nucl Med & Mol Imaging, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[4] Leopoldina Hosp Schweinfurt, Schweinfurt, Germany
关键词
Hypertrophic obstructive cardiomyopathy; Septal ablation; PTSMA; Magnetic resonance imaging; MRI; Myocardial scar; VENTRICULAR OUTFLOW TRACT;
D O I
10.1016/j.ijcard.2008.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Contrast enhanced cardiac magnetic resonance imaging (MRI) 11 years after the PTSMA demonstrated extensive scarring, in septal and inferior segments of the left ventricle, and an excellent functional result. It has been previously demonstrated that contrast-enhanced MRI allows detailed evaluation of size and location of septal myocardial infarction induced by PTSMA, and that infarction size detected by MRI correlates well with clinical indexes of infarct size. Our case report underlines the importance of ongoing specialized care and reassessment of patients after PTSMA including continuous clinical risk assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E3 / E5
页数:3
相关论文
共 9 条
  • [1] Ethical authorship and publishing
    Coats, Andrew J. S.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) : 149 - 150
  • [2] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy - Results with respect to intraprocedural myocardial contrast echocardiography
    Faber, L
    Seggewiss, H
    Gleichmann, U
    [J]. CIRCULATION, 1998, 98 (22) : 2415 - 2421
  • [3] Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Maron, Barry J.
    Spirito, Paolo
    Shen, Win-Kuang
    Haas, Tammy S.
    Formisano, Francesco
    Link, Mark S.
    Epstein, Andrew E.
    Almquist, Adrian K.
    Daubert, James P.
    Lawrenz, Thorsten
    Boriani, Giuseppe
    Estes, N. A. Mark, III
    Favale, Stefano
    Piccininno, Marco
    Winters, Stephen L.
    Santini, Massimo
    Betocchi, Sandro
    Arribas, Fernando
    Sherrid, Mark V.
    Buja, Gianfranco
    Semsarian, Christopher
    Bruzzi, Paolo
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (04): : 405 - 412
  • [4] Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance
    Moon, JCC
    McKenna, WJ
    McCrohon, JA
    Elliott, PM
    Smith, GC
    Pennell, DJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) : 1561 - 1567
  • [5] The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization
    Schulz-Menger, J
    Strohm, O
    Waigand, J
    Uhlich, F
    Dietz, R
    Friedrich, MG
    [J]. CIRCULATION, 2000, 101 (15) : 1764 - 1766
  • [6] Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy
    Schulz-Menger, Jeanette
    Abdel-Aty, Hassan
    Busjahn, Andreas
    Wassmuth, Ralf
    Pilz, Bernhard
    Dietz, Rainer
    Friedrich, Matthias G.
    [J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2006, 8 (05) : 741 - 746
  • [7] Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H.
    Rigopoulos, A.
    Welge, D.
    Ziemssen, P.
    Faber, L.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (12) : 856 - 863
  • [8] NONSURGICAL MYOCARDIAL REDUCTION FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    SIGWART, U
    [J]. LANCET, 1995, 346 (8969): : 211 - 214
  • [9] Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy
    Valeti, Uma S.
    Nishimura, Rick A.
    Holmes, David R.
    Araoz, Philip A.
    Glockner, James F.
    Breen, Jerome F.
    Ommen, Steve R.
    Gersh, Bernard J.
    Tajik, A. Jamil
    Rihal, Charanjit S.
    Schaff, Hartzell V.
    Maron, Barry J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (03) : 350 - 357